Therapeutic Effect of Alprostadil in Diabetic Nephropathy: Possible Roles of Angiopoietin-2 and IL-18 | Zendy

Changqing Luo | Zendy; Ting Li | Zendy; Chun Zhang | Zendy; Qing Chen | Zendy; Zhenqiong Li | Zendy; Jianshe Liu | Zendy; Yumei Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapeutic Effect of Alprostadil in Diabetic Nephropathy: Possible Roles of Angiopoietin-2 and IL-18

Author(s) -

Changqing Luo,

Ting Li,

Chun Zhang,

Qing Chen,

Zhenqiong Li,

Jianshe Liu,

Yumei Wang

Publication year - 2014

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000366309

Subject(s) - diabetic nephropathy , western blot , angiopoietin , endocrinology , kidney , intraperitoneal injection , medicine , pathogenesis , diabetes mellitus , angiogenesis , streptozotocin , proteinuria , chemistry , pharmacology , vascular endothelial growth factor , gene , biochemistry , vegf receptors

To investigate the role of angiopoietin-2 (Ang-2) and IL-18 in the pathogenesis of diabetic nephropathy (DN) and the molecular mechanisms through which alprostadil protects renal function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research